Submitted by Anonymous (not verified) on 24 November 2023 - 12:21
Human medicines European public assessment report (EPAR): Talvey, talquetamab, Multiple Myeloma, Date of authorisation: 21/08/2023, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Talvey, talquetamab, Multiple Myeloma, Date of authorisation: 21/08/2023, Revision: 1, Status: Authorised